Medicare Database Could Track Drug Safety | CIO Insight

Medicare Database Could Track Drug Safety

Written By
M.L. Baker
M.L. Baker
Jun 6, 2005
1 minute read

Medicare should combine billing data from its prescription drug program with information collected when Medicare users submit claims for hospital and doctor visits, says the head of CMS. Integrating this information in a huge database could detect potential safety problems with drugs. While the FDA currently assesses drugs’ safety problems in clinical trials with hundreds to thousands of patients, such a database could assess affects on millions of patients

So far, the FDA is not enthusiastic about the plan proposed by Mark McClellan, current head of the CMS, and former head of the Food and Drug Administration.

Read the full story by the LA Times here. (May require registration.)

CIO Insight Logo

CIO Insight offers thought leadership and best practices in the IT security and management industry while providing expert recommendations on software solutions for IT leaders. It is the trusted resource for security professionals who need to maintain regulatory compliance for their teams and organizations. CIO Insight is an ideal website for IT decision makers, systems integrators and administrators, and IT managers to stay informed about emerging technologies, software developments and trends in the IT security and management industry.

Property of TechnologyAdvice. © 2026 TechnologyAdvice. All Rights Reserved

Advertiser Disclosure: Some of the products that appear on this site are from companies from which TechnologyAdvice receives compensation. This compensation may impact how and where products appear on this site including, for example, the order in which they appear. TechnologyAdvice does not include all companies or all types of products available in the marketplace.